ARK Invest's position in ALMR, updated every trading day. Data as of 2026-11-12.
| Fund | Shares | Value | Weight | Rank |
|---|---|---|---|---|
| ARKG | 1,199,824 | $38.1M | 1.93% | #19 |
| Trade day | Fund | Side | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-12 | ARKG | Buy | Added | 101,154 | $2.5M |
| 2026-10-09 | ARKG | Buy | Added | 31,068 | $785K |
| 2026-07-16 | ARKG | Buy | Added | 37,822 | $944K |
| 2026-07-15 | ARKG | Buy | Added | 29,223 | $764K |
| 2026-07-14 | ARKG | Buy | Added | 10,424 | $282K |
| 2026-07-13 | ARKG | Buy | Added | 37,003 | $1.0M |
| 2026-07-10 | ARKG | Buy | Added | 1,991 | $57K |
| 2026-07-09 | ARKG | Buy | Added | 676 | $18K |
| 2026-07-08 | ARKG | Buy | Added | 20,644 | $522K |
| 2026-07-07 | ARKG | Buy | Added | 18,183 | $459K |
| 2026-07-06 | ARKG | Buy | Added | 37,947 | $974K |
| 2026-07-02 | ARKG | Buy | Added | 12,996 | $337K |
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and…
See ALMR's full ARK history since 2024, ARK's estimated cost basis, the conviction score and buy/sell alerts.
Open ALMR on FundWake →Data comes from ARK Invest's public daily holdings and trade files. FundWake is not affiliated with ARK Invest. Nothing here is investment advice.